Trial · NCT04518410
Participant flow75
How many started, completed or left each group, period by period.
1 to 20 of 75
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Bamlanivimab 7000 mg (Phase 2) | 48 | |
| Overall Study | STARTED | Bamlanivimab 7000mg Placebo (Phase 2) | 46 | |
| Overall Study | STARTED | Bamlanivimab 700mg (Phase 2) | 111 | |
| Overall Study | STARTED | Bamlanivimab 700mg Placebo (Phase 2) | 114 | |
| Overall Study | STARTED | Bamlanivimab 700mg (Phase 3) | 1,079 | |
| Overall Study | STARTED | BRII-196+BRII-198 (Pooled Phase 2/3) | 424 | |
| Overall Study | STARTED | BRII-196+BRII-198 Placebo (Pooled Phase 2/3) | 422 | |
| Overall Study | STARTED | AZD7442 (IV) (Phase 2) | 61 | |
| Overall Study | STARTED | AZD7442 (IV) Placebo (Phase 2) | 33 | |
| Overall Study | STARTED | AZD7442 (IM) (Phase 2) | 110 | |
| Overall Study | STARTED | AZD7442 (IM) Placebo (Phase 2) | 54 | |
| Overall Study | STARTED | SNG001 (Phase 2) | 110 | |
| Overall Study | STARTED | SNG001 Placebo (Phase 2) | 53 | |
| Overall Study | STARTED | Camostat (Phase 2) | 113 | |
| Overall Study | STARTED | Camostat Pooled Placebo (Phase 2) | 54 | |
| Overall Study | STARTED | SAB-185 (Low Dose) (Phase 2) | 110 | |
| Overall Study | STARTED | SAB-185 (Low Dose) Placebo (Phase 2) | 39 | |
| Overall Study | STARTED | SAB-185 (Low Dose) (Phase 3) OMICRON Population | 225 | |
| Overall Study | STARTED | Casirivimab and Imdevimab (Phase 3) OMICRON Population | 214 | |
| Overall Study | STARTED | SAB-185 (Low Dose) (Phase 3) Non-OMICRON Population | 142 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04518410/flow